Role of GABA during the multiple consolidation of memory

Drug Development Research

Volumn 28, Issue 1, 1993, Pages 3-27

  Brioni, Jorge D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Alzheimer's disease; amygdala; diazepam; GABA; hippocampus; memory

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; AMINOOXYACETIC ACID; AMOBARBITAL; AMYLOID BETA PROTEIN; BACLOFEN; BARBITAL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA CARBOLINE DERIVATIVE; BICUCULLINE; CHLORDIAZEPOXIDE; DIAZEPAM; FLUMAZENIL; GABOXADOL; LORAZEPAM; MIDAZOLAM; MUSCIMOL; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; PENTOBARBITAL; PICROTOXIN; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; SURITOZOLE; THIOPENTAL; UNINDEXED DRUG; VALPROIC ACID;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GABAERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LONG TERM POTENTIATION; MEMORY; MOUSE; NEUROTRANSMISSION; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; REVIEW; SENILE DEMENTIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0027472215     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430280103     Document Type: Review

References (254)

1. An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat
2. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease
3. Diazepam impairs place learning in the Morris water maze
4. Levels of γ‐aminobutyric acid in cerebrospinal fluid in various neurologic disorders
5. Factor I and γ‐aminobutyric acid
6. Muscimol binding in rat brain: Association with synaptic GABA receptors
7. Regional distribution of glutamate decarboxylase and GABA within the amygdaloid complex and stria terminalis of the rat
8. Ligand‐gated ion channels in the brain: the aminoacid receptor superfamily
9. GABA‐A vs GABA‐B modulation of septal–hippocampal interconnections
10. Innate and conditioned reactions to threat in rats with amygdaloid lesions
11. Long‐lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path
12. Electrophysiology of GABA‐A and GABA‐B receptor subtypes
13. Effects of posttrial administration of drugs on avoidance learning on mice
14. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease
15. Baclofen: 10 years on
16. GABA‐B receptors and their significance in mammalian pharmacology
17. (‐)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
18. Characteristics of GABA‐B receptor binding sites on rat whole brain synaptic membranes
19. Distribution of GABAergic and cholinergic neurons in the rat diagonal band
20. Facilitation of maze learning with post–trial injections of picrotoxin
21. Diazepam impairs retention of spatial information without affecting retrieval or cue learning
22. Post‐training administration of GABAergic antagonists enhances retention of aversively motivated tasks
23. Involvement of the amygdala GABAergic system in the modulation of memory storage
24. Muscimol injections in the medial septum impair spatial learning
25. The effect of flumazenil on acquisition, retention and retrieval of spatial information
26. The comparative effects of benzodiazepines, progabide and PK 9084 on acquisition of passive avoidance in mice
27. Amygdaloid complex lesions differentially affect retention of tasks using appetitive and aversive reinforcement
28. Effects of post‐training bicuculline and muscimol on retention: Lack of state dependency
29. Oxotremorine attenuates retrograde amnesia induced by post‐training administration of the GABAergic agonists muscimol and baclofen
30. Oxotremorine attenuates retrograde amnesia induced by post‐training administration of the GABAergic agonists muscimol and baclofen
31. Effects of ethanol on passive avoidance behavior in the mouse: Involvement of GABAergic mechanisms
32. Effect of ethanol on memory consolidation in mice: Antagonism by the imidazobenzodiazepine RO 15–4513 and decrement by familiarization with the environment
33. Post‐training systemic and intra‐amygdala administration of the GABA‐B agonist baclofen impairs retention
34. GABAergic modulation of memory
35. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase
36. Intraseptal administration of muscimol produced dose‐dependent memory impairments in the rat
37. Cortical GABA‐B and GABA‐A receptors in Alzheimer's disease
38. Quantitative autoradiography of hippocampal GABA‐B and GABA‐A receptors changes is Alzheimer's disease
39. The amnesic effect of diazepam (Valium)
40. Preserved learning and retention of pattern‐analyzing skill in amnesia: Dissociation of knowing how and knowing that
41. The transsynaptic regulation of the septal‐hippocampal cholinergic neurons
42. Effect of post‐training injections of flumazenil into the amygdala, hippocampus ans septum on retention of habituation and of inhibitory avoidance in rats
43. GABA, bicuculline and central inhibition
44. Amnesia caused by herpex simplex encephalitis, infarctions in basal forebrain, Alzheimer's disease and anoxia/ischemia
45. Neurotransmitter‐related enzymes in senile dementia of the Alzheimer's type
46. Selective loss of central cholinergic neurons in Alzheimer's disease
47. The role of the amygdala in fear and anxiety
48. Differential effects of medial septal lesions on spatial‐memory tasks
49. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory
50. A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice
51. The role of cholinergic projections from the nucleus basalis in memory
52. Triazolam and diazepam block LTP in rat hippocampal and pyriform cortex slices
53. Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex
54. Stiff‐man syndrome and dementia
55. GABAergic control of basal forebrain cholinergic neurons and memory
56. Failure of chlordiazepoxide to reproduce the behavioral effects of muscimol administered into the basal forebrain
57. Human studies on the benzodiazepine receptor antagonist β‐carboline ZK 93426: Preliminary observation on psychotropic activity
58. Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat
59. The hippocampus‐what does it do?
60. Properties of γ‐aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions
61. Cerebrospinal fluid γ‐aminobutyric acid variations in neurological disorders
62. Peripheral GABAergic mechanisms
63. γ‐aminobutyric acid outside the mammalian brain
64. Late posttraining memory processing by entorhinal cortex: involvement of NMDA and GABAergic receptors
65. Dehydroepiandrosterone sulfate improves memory in aging mice
66. Dehydroepiandrosterone and its sulfate enhance memory retention in mice
67. The release of an inhibitory substance from mammalian brain, and its effect on peripheral synaptic transmission
68. Memory formation: Evidence for a specific neurochemical system in the amygdala
69. β‐adrenergic manipulation in amygdala central nucleus alers rabbit heart rate conditioning
70. Opiate effects in the amygdala central nucleus on heart rate conditioning in rabbits
71. Opioid peptides: Their position among other neuroregulators of memory
72. Consolidation and maze learning: The effect of post‐trial injections of a depressant drug (pentobarbital sodium)
73. The effects of meprobamate, barbiturates, D‐amphetamine and promazine of experimentally induced conflict in the rat
74. GABAergic neurons in the entorhinal cortex project to the hippocampus
75. Enhancement of endogenous release of glutamate and γ‐aminobutyric acid from hippocampus CAI slices after in vivo long‐term potentiation
76. Time course of antagonism of sedative and amnesic effects of diazepam by flumazenil
77. Cholinergic and GABAergic modulation of medial septal area: Effect on working memory
78. Glucose modulation of memory storage processing
79. Retrograde amnesia produced by subseizure amygdaloid stimulation
80. The antiaversive action of minor tranquilizers
81. Differential effects of intrahippocampally or systemically applied picrotoxin on memory consolidation in rats
82. The actions of γ‐aminobutyric acid and related amino acids on mammalian autonomic ganglia
83. Cloning and expression of a rat brain GABA transporter
84. Physiological mechanisms underlying long‐term potentiation
85. The effect of γ‐vinyl GABA on the performance of nucleus basalis‐lesioned rats in spatial navigation task
86. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
87. A disorder of cortical GABAergic innervation is Alzheimer's disease
88. 3H‐GABA bind to bicuculline‐insensitive GABA‐B sites in rat brain
89. Effects of cholinergic and monoaminergic antagonists and tranquilizers upon spatial memory in rats
90. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm
91. Effects of γ‐aminobutyric acid on the isolated mammalian ileum
92. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: Critical review of the clinical literature
93. Development of a class of selective cholecystokinin type B receptor antagonists having Potent anxiolytic activity
94. Selective antagonists of benzodiazepines
95. Alzheimer's disease: Cell specific pathology isolates the hippocampal formation
96. Memory‐related neural systems in Alzheimer's disease: An anatomic study
97. Interaction of hormones and neurotransmitter systems in the modulation of memory storage
98. Intrinsic neurons in the amygdaloid field projected by the medial geniculate body mediate emotional responses conditioned to acoustic stimuli
99. Endogenous state‐dependency: Memory depends on the relation between the neurohumoral and hormonal states present after training and at the time of testing
100. Different forms of post–training memory processing
101. Posttraining down‐regulation of memory consolidation by a GABA‐A mechanism in the amygdala modulated by endogenous benzodiazepines
102. Benzodiazepine receptor ligand influences acquisition: Suggestion of an endogenous modulatory mechanism mediated by benzodiazepines receptors
103. GABA‐A receptor modulation of memory: The role of endogenous benzodiazepines
104. Inhibition of baclofen‐induced hypothermia in mice by the novel GABA‐B antagonist CGP 35348
105. Evaluation of the β‐carboline ZK 93426 as a benzodiazepine antagonist
106. Bidirectional effects of β‐carboline and benzodiazepines on cognitive processes
107. GABA as an autonomic neurotransmitter: Studies on intrinsic GABAergic neurons in the myenteric plexus of the gut
108. Multiplicity of GABA receptors
109. 3 receptor antagonist
110. Inhibition of 3H‐GABA binding by bicuculline related alkaloids
111. Differential mechanism involved in the anticonflict action of benzodiazepines injected into the central amygdala and mamillary body
112. GABA involvement in memory consolidation: Evidence from posttrial amino–oxyacetic acid
113. 2–hydroxy‐saclofen: An improved antagonist at central and peripheral GABA‐B receptors
114. Phaclofen: A peripheral and central baclofen antagonist
115. An attribute analysis of memory: The role of the hippocampus
116. The role of the amygdala within an attribute analysis of memory
117. Reevaluation of the contribution of the basal forebrain cholinergic system to memory
118. Serial position curves for item (spatial location) information: Role of the dorsal hippocampal formation and medial septum
119. Dose‐response evaluation of the amnesic effects of triazolam and pentobarbital in normal subjects
120. An analysis of certain effects of bilateral temporal lobectomy in the rhesus monkey, with special reference to “psychic blindness”
121. Septal neurons containing glutamic acid decarboxylase inmunoreactivity project to the hippocampal region in the rat brain
122. The action of γ‐aminobutyric acid on cortical neurons
123. A new class of GABA agonist
124. CGS‐8216, a benzodiazepine receptor antagonist, enhances learning and memory in mice
125. Flumazenil improves active avoidance performance in aging NZB/B1NJ and C57BL/6NNia mice
126. Enhancement of learning and memory in mice by a benzodiazepine antagonist
127. The effect of strychnine and caffeine upon rate of learning
128. Interruption of projections from the medial geniculate body to an archi‐neostriatal field disrupts the classical conditioning of emotional acoustic stimuli
129. The lateral amygdaloid nucleus: Sensory interface of the amygdala in fear conditioning
130. A comparison of the effects of ECS and aesthesia on acquisition of the maze habit
131. Post‐training amygdaloid lesions impair retention of an inhibitory avoidance response
132. The amnesic action of benzodiazepines in man
133. Is Ro 15‐4513 a specific alcohol antagonist?
134. GABA‐A receptor complex function in frontal cortex membranes from control and neurological patients
135. New perspectives on the physiology, chemistry, and pharmacology of memory
136. Chronic infusion of GABA and saline into the nucleus basalis magnocellularis of rats: Cognitive impairments
137. Steroid hormone metabolites are barbiturate‐like modulators of the GABA receptor
138. Pregnenolone sulfate antagonizes barbiturate‐induced hypnosis
139. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA‐A receptor
140. Kinetic regulation of convulsant (TBPS) binding by GABAergic agents
141. Regulatory properties of brain glutamate decarboxylase (GAD): The apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD
142. Immunohistochemical identification of γ‐aminobutyric acid‐containing neurons in the rat basolateral amygdala
143. A Time‐dependent processes in memory storage
144. Drug facilitation of learning and memory
145. Hormonal influence on memory
146. Dissociating learning and performance: Drug and hormone enhancement of memory storage
147. Memory‐enhancing effects of posttraining naloxone: Involvement of β‐noradrenergic influences in the amygdaloid complex
148. Picrotoxin enhance latent extinction of conditioned fear
149. Involvement of the amygdaloid complex in meuromodulatory influences on memory storage
150. Effect of flumazenil on midazolam‐induced amnesia
151. Diazepam impair acquisition but not performance in the Morris water maze
152. Assessment of a cholinergic contribution to chlordiazepoxide‐induced deficits of place learning in the Morris water maze
153. Chlordiazepoxide, an anxiolytic benzodiazepine, impairs place navigation in rats
154. Diazepam and memory: Support for a duplex model of memory
155. Study of short‐term memory after intracarotid injection of sodium amytal
156. The effects of n‐dipropylacetate on the acquisition of conditioned behaviour with negative reinforcement in mice
157. Benzodiazepine receptor: Demonstration in the central nervous system
158. GABA‐Agonist therapy for Alzheimer's disease
159. The effects of Various antiepileptic drugs on E‐shock‐induced amnesia in mice: Dissociability of effects on convulsions and effects on memory
160. Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABA‐A receptor complex
161. Synaptic plasticity and learning: Selective impairment in rats and blockade of long‐term potentiation in vivo by the N‐methyl‐D‐aspartate receptor antagonist AP5
162. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry
163. Amygdalectomy impairs cross‐modal association in monkeys
164. GABAergic modulation of memory with regard to passive avoidance and conditioned suppression tasks in mice
165. Effects of intraseptal infusion of muscimol on inhibitory avoidance and spatial learning: differential effects of pretraining and posttraining administration
166. Enhanced inhibitory avoidance learning produced by posttrial injections of substance P into the basal forebrain
167. Anti‐anxiety action diazepam after intra‐amygdaloid application in the rat
168. Distribution of GABA‐like inmunoreactivity in the rat amygdaloid complex
169. Organizational and synaptic interconnections of GABAergic and cholinergic elements in the rat amygdaloid nuclei: Single‐ and double‐inmunolabeling studies
170. RO 15‐1788 antagonizes the effects of diazepam in man without affecting its bioavailability
171. Amygdala
172. The effects of baclofen and two GABA‐B receptor antagonists on long term potentiation
173. CGP 35348: A centrally active blocker of GABA‐B receptors
174. GABA‐Benzodiazepine‐barbiturate interactions
175. Molecular biology of the GABA‐A receptor
176. Hippocampal connections and spatial discrimination
177. Hippocampal space and memory
178. An ultrastructural study of GABA‐inmunoreactive neurons and terminals in the septum of the rat
179. Effects of thiopental sedation on learning and memory
180. An inmunohistochemical study on the location of GABAergic neurons in rat septum
181. GABA and behavior: The role of receptor subtypes
182. Effect of pre‐training flumazenil administration on the acquisition of three different tasks in rats
183. Neurotransmitter enzyme abnormalities in senile dementia
184. Diazepam and human memory: Influence on acquisition, retrieval and state‐dependent learning
185. N‐methyl bicuculline, a convulsant more potent than bicuculline
186. Learning and memory‐enhancing effects of RO 15–4513: A comparison with flumazenil
187. Importance of a novel GABA‐A receptor subunit for benzodiazepine pharmacology
188. Purification and identification of the functional sodium‐ and chloride‐coupled γ‐aminobutyric acid transport glycoprotein from rat brain
189. Similar effects of a β‐carboline and of flumazenil in negatively and positively reinforced learning tasks in mice
190. GABA‐ergic drugs: Effects on conditioning, memory and learning
191. Pre‐ and Postsynaptic neurochemical alterations in Alzheimer's disease
192. Inhibition of high‐affinity choline uptake in the rat hippocampus by in vivo injection of phenobarbital in the medial septum
193. Well–kept secrets of the right hemisphere: A carotid amytal study of restricted memory transfer
194. Introduction
195. Cognitive enhancing agents for the treatment of senile dementia of the Alzheimer's type
196. A post‐mortem study of the cholinergic and GABA systems in senile dementia
197. Neurochemical mapping of GABAergic systems in the amygdaloid complex and bed nucleus of the stria terminalis
198. N‐Methyl‐d‐aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear–potentiated startle and shock sensitization of startle
199. Baclofen‐induced memory impairment
200. Demonstration of benzodiazepine‐like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines
201. Release of γ‐aminobutyric acid from synaptosomes: Effect of external cations and of ouabain
202. Retrieval of Well‐learned propositional rules: Insensitive to changes in activity of individual neurotransmitters systems?
203. Taking stock of cognition enhancers
204. Involvement of the amygdala in learning and memory: A critical review with emphasis on anatomical relations
205. Treatment strategies for senile dementia: Antagonist β‐carbolines
206. Activating the damaged basal forebrain cholinergic system: Tonic stimulation versus signal amplification
207. Behavioral screening for cognition enhancers: From indiscriminate to valid testing: Part 1
208. Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala
209. Sequence and functional expression of the GABA‐A receptor shows a ligand‐gated receptor super‐family
210. Loss of recent memory after bilateral hippocampal lesions
211. Relationship of gamma‐aminobutyric acid (GABA) to antianxiety effects of benzodiazepines
212. Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats
213. Changes in benzodiazepine receptors in Alzheimer's type dementia
214. Potential interactions between GABA‐B and cholinergic systems: Baclofen augments scopolamine‐induced performance deficits in the eight‐arm radial maze
215. GABA receptor mechanisms in the central nervous system
216. Autoantibodies to glutamic acid decarboxylase in a patient with stiff‐man syndrome, epilepsy, and type I diabetes mellitus
217. Autoantibodies to GABA‐ergic neurons and pancreatic beta cells in Stiff‐man syndrome
218. An electrophysiological comparison of MDL 26,479, a novel triazole, and beta‐carbolines in the hippocampal slice: Evidence for cognition enhancing potential
219. Benzodiazepine receptors in rat brain
220. Chlordiazepoxide‐induced working memory impairments: Site specificity and reversal by flumazenil
221. Antagonism of NMDA receptors impairs acquisition but not retention of olfactory memory
222. Clinical studies of induction agents. XXV: Diazepam
223. Configural association theory: The role of the hippocampal formation in learning, memory, and amnesia
224. Baclofen disrupts passive avoidance retention in rats
225. Some evidence for the amnesic‐like effects of benzodiazepines in animals
226. Sodium valproate and cognitive functioning in normal volunteers
227. Amygdala lesions block the amnesic effects of diazepam
228. Basolateral amygdala lesions block diazepam‐induced anterograde amnesia in an inhibitory avoidance task
229. Effects of sodium barbitone on learning and memory‐storage of an appetitive and an aversive task
230. Benzodiazepine impairs and β‐carboline enhances performance in learning and memory tasks
231. Laminar alterations in γ‐aminobutyric acid‐A, muscarinic, and β‐adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease
232. Alternatives in the treatment of memory loss in patients with Alzheimer's disease
233. Glutamic acid decarboxylase‐like immunoreactive neurites in senile plaques
234. Amnesia: Consolidation or retrieval
235. Pharmacological manipulations of the sustantia innominata‐cortical cholinergic pathway
236. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers
237. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
238. Facilitated induction of hippocampal long‐lasting potentiation during blockade of inhibition
239. Diazepam and N‐methyl‐diazepam are found in rat brain and adrenal and may be of plant origin
240. The effect of sodium phenobarbital on the learning behaviour of white rats
241. Loss of hippocampal theta rhythm results in spatial memory deficit in the rat
242. Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine‐like molecules and are affected by intracerebral flumazenil microinjection
243. GABAergic regulations of the substantia innominata‐cortical cholinergic pathway
244. Purification and characterization of glutamate decarboxylase from mouse brain
245. Effect of picrotoxin on adrenal catecholamine secretion
246. Memory effects of GABAergic antagonists in rats trained with two‐way active avoidance tasks
247. γ‐aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type
248. Human amnesia and the medical temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus
249. γ‐aminobutyric acid binding to receptor sites in the rat central nervous system